Erika Cione Selected Research

JY-1-106

5/2018	Therapeutic potential of Bcl-xL/Mcl-1 synthetic inhibitor JY-1-106 and retinoids for human triple-negative breast cancer treatment.
10/2014	BCL-xL/MCL-1 inhibition and RARγ antagonism work cooperatively in human HL60 leukemia cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erika Cione Research Topics

Disease

11	Neoplasms (Cancer) 05/2022 - 09/2009
7	Drug-Related Side Effects and Adverse Reactions 01/2022 - 01/2016
6	Breast Neoplasms (Breast Cancer) 04/2022 - 09/2009
5	Type 2 Diabetes Mellitus (MODY) 12/2021 - 10/2017
5	Migraine Disorders (Migraine) 06/2019 - 01/2017
4	Obesity 12/2021 - 12/2010
4	Pain (Aches) 06/2019 - 12/2017
3	COVID-19 05/2022 - 01/2021
3	Inflammation (Inflammations) 01/2021 - 09/2012
3	Wounds and Injuries (Trauma) 04/2020 - 01/2019
3	Triple Negative Breast Neoplasms 04/2019 - 05/2018
2	Insulin Resistance 12/2021 - 01/2016
2	Infections 11/2021 - 01/2019
2	Prostatitis 09/2021 - 03/2021
2	Noncommunicable Diseases 09/2021 - 12/2019
2	Neuralgia (Stump Neuralgia) 01/2020 - 01/2018
2	Varicocele 12/2018 - 05/2015
2	Male Infertility (Male Sterility) 12/2018 - 05/2015
2	B-Cell Lymphoma (Lymphoma, B Cell) 05/2018 - 10/2014
2	Carcinogenesis 12/2017 - 04/2008
1	Lung Neoplasms (Lung Cancer) 05/2022
1	Osteoporosis 04/2022
1	Metabolic Bone Diseases (Osteopenia) 04/2022
1	Skin Neoplasms (Skin Cancer) 01/2022
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Lipedema 12/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2021
1	Sarcopenia 09/2021
1	Phlebitis 06/2021
1	Venous Insufficiency 06/2021
1	Vascular Diseases (Vascular Disease) 06/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 06/2021
1	Pelvic Pain 03/2021
1	Edema (Dropsy) 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Lung Injury 01/2021
1	Diabetes Mellitus 04/2020
1	Ulcer 04/2020

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 01/2022 - 01/2017
6	Biomarkers (Surrogate Marker)IBA 09/2021 - 01/2017
5	MicroRNAs (MicroRNA)IBA 12/2021 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 09/2021 - 09/2009
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 12/2010
3	Vitamin D FDA LinkGeneric 11/2021 - 01/2019
3	AntioxidantsIBA 01/2019 - 09/2010
3	Vitamin A (Retinol)FDA LinkGeneric 12/2018 - 05/2015
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2018 - 04/2008
3	RetinoidsIBA 05/2018 - 09/2010
3	Messenger RNA (mRNA)IBA 05/2017 - 09/2009
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2022 - 01/2020
2	EnzymesIBA 05/2022 - 09/2010
2	Cholecalciferol (Vitamin D3)FDA Link 04/2022 - 06/2019
2	hydroxide ionIBA 04/2022 - 11/2021
2	Estrogen ReceptorsIBA 04/2022 - 05/2018
2	Hyaluronic Acid (Hyaluronan)IBA 03/2021 - 04/2020
2	VitaminsIBA 03/2021 - 01/2019
2	PolyphenolsIBA 12/2019 - 12/2017
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2019 - 01/2019
2	JY-1-106IBA 05/2018 - 10/2014
2	AmidesIBA 01/2018 - 01/2018
2	Ethanol (Ethyl Alcohol)IBA 01/2018 - 01/2018
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018 - 12/2017
2	Oncogene Proteins (Oncogene Protein)IBA 04/2017 - 06/2013
2	Biological ProductsIBA 01/2016 - 04/2008
2	Rosiglitazone (Avandia)FDA Link 07/2011 - 09/2009
2	LigandsIBA 07/2011 - 09/2009
1	Mevalonic Acid (Mevalonate)IBA 05/2022
1	Oxidoreductases (Dehydrogenase)IBA 05/2022
1	Coenzyme A (CoA)IBA 05/2022
1	N-(2-cyanoethylene)urea (BA 1)IBA 05/2022
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 05/2022
1	CalciumIBA 04/2022
1	Parathyroid Hormone (Parathormone)IBA 04/2022
1	Aromatase InhibitorsIBA 04/2022
1	Calcifediol (Calcidiol)FDA Link 04/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	ORALIT (ORS)IBA 01/2022
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2022
1	Interleukin-6 (Interleukin 6)IBA 11/2021
1	CreatineIBA 09/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2021
1	Fondaparinux (Arixtra)FDA Link 06/2021
1	Enoxaparin (Lovenox)FDA LinkGeneric 06/2021
1	nattokinaseIBA 06/2021
1	AnticoagulantsIBA 06/2021
1	GlucocorticoidsIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	EscinIBA 01/2021
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021
1	HydrogelsIBA 04/2020

Therapy/Procedure

10	Therapeutics 05/2022 - 01/2016
6	Drug Therapy (Chemotherapy) 05/2022 - 01/2016
1	Radiotherapy 05/2022
1	Ketogenic Diet 12/2021
1	Mediterranean Diet 09/2021
1	Glycemic Control 07/2021